Amid a big corporate restructuring, AstraZeneca PLC confirmed Feb. 14 that it is retiring the name MedImmune LLC as it combines its large and small molecule research.
MedImmune has operated in Gaithersburg, Md., with some autonomy since it was acquired by AstraZeneca in 2007, and has been...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?